265 related articles for article (PubMed ID: 3021173)
1. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
Ozaki Y; Ohashi T; Niwa Y
Biochem Pharmacol; 1986 Oct; 35(20):3481-8. PubMed ID: 3021173
[TBL] [Abstract][Full Text] [Related]
2. Effect of the 5-lipoxygenase inhibitor piriprost on superoxide production by human neutrophils.
Flament J; Schandene L; Boeynaems JM
Prostaglandins Leukot Essent Fatty Acids; 1988 Dec; 34(3):175-80. PubMed ID: 2851839
[TBL] [Abstract][Full Text] [Related]
3. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
Ward PA; Sulavik MC; Johnson KJ
Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
[TBL] [Abstract][Full Text] [Related]
4. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4.
Dewald B; Baggiolini M
Biochem Biophys Res Commun; 1985 Apr; 128(1):297-304. PubMed ID: 2985075
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
Billah MM; Bryant RW; Siegel MI
J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982
[TBL] [Abstract][Full Text] [Related]
6. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis.
Palmer RM; Salmon JA
Biochem Pharmacol; 1985 May; 34(9):1485-90. PubMed ID: 2986647
[TBL] [Abstract][Full Text] [Related]
8. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo.
Kaplan HB; Edelson HS; Korchak HM; Given WP; Abramson S; Weissmann G
Biochem Pharmacol; 1984 Feb; 33(3):371-8. PubMed ID: 6422946
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophil migration in vitro induced by secretory phospholipases A2: a role for cell surface glycosaminoglycans.
Gambero A; Landucci EC; Toyama MH; Marangoni S; Giglio JR; Nader HB; Dietrich CP; De Nucci G; Antunes E
Biochem Pharmacol; 2002 Jan; 63(1):65-72. PubMed ID: 11754875
[TBL] [Abstract][Full Text] [Related]
11. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
12. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
Glaser KB; Lock YW; Chang JY
Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
[TBL] [Abstract][Full Text] [Related]
13. 5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils.
Wijkander J; O'Flaherty JT; Nixon AB; Wykle RL
J Biol Chem; 1995 Nov; 270(44):26543-9. PubMed ID: 7592874
[TBL] [Abstract][Full Text] [Related]
14. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
Hopkins NK; Schaub RG; Gorman RR
Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism.
Hamasaki T; Sakano T; Kobayashi M; Sakura N; Ueda K; Usui T
Eur J Clin Invest; 1989 Aug; 19(4):404-11. PubMed ID: 2550242
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism.
Damtew B; Spagnuolo PJ
Inflammation; 1992 Oct; 16(5):425-36. PubMed ID: 1330924
[TBL] [Abstract][Full Text] [Related]
18. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis.
Gaudreault E; Stankova J; Rola-Pleszczynski M
Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):25-34. PubMed ID: 15789613
[TBL] [Abstract][Full Text] [Related]
19. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):45-9. PubMed ID: 2169061
[TBL] [Abstract][Full Text] [Related]
20. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
